IRIS
LEONARDI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.736
AS - Asia 2.713
EU - Europa 2.504
SA - Sud America 522
AF - Africa 70
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.553
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.613
CN - Cina 880
SG - Singapore 840
IE - Irlanda 786
HK - Hong Kong 542
RU - Federazione Russa 451
BR - Brasile 435
DE - Germania 356
IT - Italia 248
FI - Finlandia 191
VN - Vietnam 132
GB - Regno Unito 92
AT - Austria 70
IN - India 67
CA - Canada 66
NL - Olanda 62
JP - Giappone 47
MX - Messico 41
SE - Svezia 38
PL - Polonia 35
FR - Francia 34
AR - Argentina 33
IQ - Iraq 29
TR - Turchia 28
UA - Ucraina 28
ES - Italia 26
BD - Bangladesh 24
ZA - Sudafrica 21
AE - Emirati Arabi Uniti 17
BE - Belgio 16
PH - Filippine 14
CO - Colombia 12
CL - Cile 10
ID - Indonesia 10
MA - Marocco 10
PK - Pakistan 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
EC - Ecuador 9
LT - Lituania 9
MK - Macedonia 9
JO - Giordania 8
CZ - Repubblica Ceca 7
UY - Uruguay 7
PE - Perù 6
AL - Albania 5
EG - Egitto 5
IL - Israele 5
KE - Kenya 5
KZ - Kazakistan 5
PA - Panama 5
RS - Serbia 5
VE - Venezuela 5
AU - Australia 4
BG - Bulgaria 4
DZ - Algeria 4
MU - Mauritius 4
NP - Nepal 4
PT - Portogallo 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
CH - Svizzera 3
CR - Costa Rica 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
IR - Iran 3
JM - Giamaica 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
PY - Paraguay 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UG - Uganda 3
AO - Angola 2
CM - Camerun 2
DK - Danimarca 2
GA - Gabon 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GY - Guiana 1
KW - Kuwait 1
Totale 10.541
Salva come PNG Salva come JPEG
Città #
Dublin 785
Chandler 552
Hong Kong 537
San Jose 507
Ashburn 487
Dallas 458
Singapore 324
Beijing 254
Los Angeles 164
Boardman 161
New York 161
Princeton 143
Munich 140
Lawrence 138
Medford 136
Helsinki 128
Wilmington 112
Redondo Beach 74
Moscow 71
Nuremberg 65
Pavia 59
Shanghai 54
Buffalo 51
Ho Chi Minh City 48
Turku 48
Tokyo 43
Jacksonville 42
Milan 41
Nanjing 39
Chicago 37
São Paulo 37
Council Bluffs 36
Falkenstein 35
Warsaw 35
Vienna 33
Hanoi 30
Norwalk 28
Washington 27
Brooklyn 25
Changsha 25
Rio de Janeiro 25
Montreal 23
Toronto 22
Chennai 21
Orem 21
Hangzhou 20
Santa Clara 20
The Dalles 20
Fairfield 18
Seattle 18
San Francisco 17
Woodbridge 17
Ankara 16
Atlanta 16
Hebei 16
Johannesburg 15
Poplar 15
Amsterdam 14
Belo Horizonte 14
Brussels 14
Denver 14
Guangzhou 14
London 14
Redwood City 14
Tomsk 14
Ann Arbor 13
Mexico City 13
Stockholm 13
Nanchang 12
Boston 11
Curitiba 10
Phoenix 10
Baghdad 9
Columbus 9
Düsseldorf 9
Frankfurt am Main 9
Houston 9
New Delhi 9
Porto Alegre 9
Tashkent 9
Tianjin 9
Amman 8
Dearborn 8
Jiaxing 8
Shenyang 8
Falls Church 7
Haiphong 7
Hyderabad 7
Lauterbourg 7
Manassas 7
Mariglianella 7
Wuhan 7
Zhengzhou 7
Karachi 6
Mumbai 6
Paris 6
Querétaro 6
Rome 6
Salvador 6
Bologna 5
Totale 6.894
Salva come PNG Salva come JPEG
Nome #
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure 260
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment 143
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 125
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 123
Alirocumab and cardiovascular outcomes after acute coronary syndrome 117
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 106
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 106
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 104
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes 103
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 102
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 100
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 100
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group 100
Aspirin Desensitization in Patients with Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease). 98
DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients 96
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 95
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 94
Utilità della risonanza magnetica cardiaca nella valutazione del profilo emodinamico di pazienti con ipertensione polmonare post-embolica: uno studio di confronto con il cateterismo cardiaco destro. 93
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 93
Sotagliflozin in patients with diabetes and recent worsening heart failure 93
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 91
Rivaroxaban with or without aspirin in stable cardiovascular disease 89
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 88
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study 88
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 88
Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention 88
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 87
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 86
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 86
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 86
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 86
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 86
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 85
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 82
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial 82
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 82
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 82
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 79
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 78
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 78
Role of cardiac magnetic resonance in the avaluation of the hemodynamic profile of patients with severe chronic thromboembolic pulmonary hypertension: a comparison with right heart catheterization 77
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study 77
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol 77
Usefulness of cardiac megnetic resonance in assessing reverse right ventricular remodeling in patients with chronic thromboembolic pulmonary hypertension after pulmonary endarteriectomy 75
Acute Cardiovascular Care 2019 75
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes 75
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor? 75
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study. 74
Parenteral antithrombotic therapy during primary percutaneous coronary intervention 74
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis 72
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 71
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes 70
The prognostic value of serial troponin measurements in patients admitted for COVID-19 70
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 69
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease 69
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY 68
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 68
Incidence of ventricular arrhythmias and 1-year predictors of mortality in patients treated with implantable cardioverter-defibrillator undergoing generator replacement 68
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY 68
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial 67
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 67
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial 66
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 66
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 66
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 65
A novel approach to systematically implement the universal definition of myocardial infarction: Insights from the CHAMPION PLATFORM trial 65
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes 65
Composition, structure, and function of heart teams: A joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization 63
Apixaban versus warfarin in patients with atrial fibrillation 63
Clinical governance of patients with acute coronary syndromes 61
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y 12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: The INNOVATE-PCI trial 61
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 61
Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function 60
Association of Troponin Levels with Mortality in Italian Patients Hospitalized with Coronavirus Disease 2019: Results of a Multicenter Study 59
Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX) 59
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome 57
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasivemanagement: Secondary analysis of a randomized clinical trial 57
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 56
Ticagrelor Alone or Conventional Dual Antiplatelet Therapy in Patients With Stable or Acute Coronary Syndromes 56
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study 55
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial 54
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patient-level data 54
Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed 54
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting 54
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study 54
Around the clock, around the world-reflections on 24 hours of acute cardiovascular care 54
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 53
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention 53
Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study 52
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 52
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score 52
Short-and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: Insights from four validated bleeding scales in the CHAMPION trials 52
Consistent Reduction in Periprocedural Myocardial Infarction with Cangrelor as Assessed by Multiple Definitions: Findings from CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition) 51
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis 51
Reduction of Hospitalizations for Myocardial Infarction in Italy in the COVID-19 Era 50
null 50
Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes 49
Antithrombotic Therapy in Patients With Acute Coronary Syndrome Complicated by Cardiogenic Shock or Out-Of-Hospital Cardiac Arrest: A Joint Position Paper From the European Society of Cardiology (ESC) Working Group on Thrombosis, in Association With the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 49
Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS 49
Use of biomarkers to predict specific causes of death in patients with Atrial fibrillation: Insights from the Aristotle Trial 49
Totale 7.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021143 0 0 0 0 0 0 5 71 23 21 9 14
2021/2022600 20 33 9 8 10 5 12 35 27 9 88 344
2022/20231.813 233 140 18 91 121 145 3 93 894 15 39 21
2023/2024823 60 170 39 39 74 239 9 64 2 45 31 51
2024/20252.824 80 165 29 55 74 218 225 158 732 143 304 641
2025/20264.124 614 433 753 657 867 230 570 0 0 0 0 0
Totale 10.794